| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $208.8M | — | +19.8% |
| Cost of Revenue | $130.9M | — | +27.4% |
| Gross Profit | $77.9M | — | +9.0% |
| R&D Expense | $38.5M | — | +25.6% |
| SG&A Expense | $19.4M | — | +1.7% |
| Operating Income | -$4.6M | — | +1.4% |
| Income Tax | -$1.5M | — | -2080.0% |
| Net Income | $4.1M | +237.3% | +210.1% |
| EPS (Basic) | $0.13 | — | +200.0% |
| EPS (Diluted) | -$0.08 | — | +38.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $47.3M | -54.0% | +31.6% |
| Short-term Investments | $3.0M | -64.7% | -48.1% |
| Accounts Receivable | $101.2M | +10.7% | +16.3% |
| Current Assets | $171.9M | -21.5% | +13.5% |
| Total Assets | $984.2M | -6.5% | +2.1% |
| Current Liabilities | $182.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $8.8M | — | +384.4% |
| Investing Cash Flow | -$3.9M | — | +72.1% |
| Financing Cash Flow | -$59.8M | — | -105.8% |
| +57.7% |
| Long-term Debt | $148.7M | -39.9% | -39.7% |
| Total Liabilities | $578.5M | -11.4% | -6.5% |
| Stockholders' Equity | $405.7M | +1.4% | +17.4% |